Amarantus Bioscience Holdings Inc (AMBS)

[barcode27]

As a reality check, I took a closer look at one of the funds mentioned in the 497 release storm yesterday (JISGX). Here are the current biotech holdings of that fund (the number following each is the market value of JPM's holding, in thousands):

ACADIA Pharmaceuticals, Inc. (a) 3,353
Acceleron Pharma, Inc. (a) 3,330
Aegerion Pharmaceuticals, Inc. (a) 4,485
AMAG Pharmaceuticals, Inc. (a) 3,618
Arrowhead Research Corp. (a) 1,184
Chimerix, Inc. (a) 2,365
Exact Sciences Corp. (a) 2,028
Halozyme Therapeutics, Inc. (a) 5,189
Insmed, Inc. (a) 2,404
Intrexon Corp. (a) 1,784
Keryx Biopharmaceuticals, Inc. (a) 2,448
Portola Pharmaceuticals, Inc. (a) 2,842
Puma Biotechnology, Inc. (a) 4,146
Synta Pharmaceuticals Corp. (a) 1,534
Threshold Pharmaceuticals, Inc. (a) 1,915

Total amount invested by JPM in biotech, just for this one fund, is 42.6M. I'm looking more closely at each of these investments right now to see if I can discern any pattern of market cap and/or catalysts vs. acquisition schedule by the fund.